Lipathrec (Glucosamine Hydrochloride)

Glucosamine hydrochloride provides the essential building block for glycosaminoglycans, which are key components of cartilage. By increasing the availability of this precursor, the supplement promotes the synthesis and repair of cartilage matrix, supporting joint function and resilience.

The appropriate dose of Lipathrec is determined by the prescribing healthcare professional based on individual health status, age, and therapeutic goals. Patients should follow the specific instructions provided by their clinician.

Safety data for glucosamine hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lipathrec.

To place an order, submit an enquiry on the Lipathrec product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lipathrec delivers glucosamine hydrochloride, a well‑studied form of glucosamine that is often preferred for its stability and bioavailability compared with glucosamine sulfate. While both forms aim to support cartilage, clinical evidence varies, and the choice may depend on individual tolerance, physician recommendation, and specific product formulations.

Lipathrec should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the lid is tightly closed to maintain potency.

Lipathrec is taken orally, typically with water. The tablet or capsule should be swallowed whole and not chewed, unless the product label specifies a different method. Follow the dosing schedule prescribed by your healthcare professional.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, significant skin reactions like Stevens‑Johnson syndrome, and potential liver enzyme elevations. Patients experiencing swelling, rash, breathing difficulty, or unusual fatigue should seek immediate medical attention.

Individuals with known hypersensitivity to glucosamine or shellfish, those on anticoagulant therapy without medical supervision, and patients with severe renal impairment should avoid using Lipathrec unless cleared by a qualified healthcare professional.